KRTAP9-9 inhibitors are a class of chemical compounds that selectively target the keratin-associated protein 9-9 (KRTAP9-9), which belongs to the larger family of keratin-associated proteins (KRTAPs). KRTAPs are essential for the structural integrity of hair and wool fibers, as they interact with keratin intermediate filaments to form the hair cortex and contribute to the stiffness and strength of hair shafts. KRTAP9-9, specifically, is part of a subset of KRTAPs that are particularly rich in cysteine residues. These residues allow for the formation of disulfide bonds, which further reinforce the cross-linking with keratin, lending additional mechanical stability and resilience to hair fibers. Inhibitors of KRTAP9-9 are structurally designed to interfere with the interactions between KRTAP9-9 proteins and keratin filaments, thereby affecting the natural assembly of these fibrous complexes.
The inhibition of KRTAP9-9 is of particular interest in material science and bioengineering due to the potential impact on the physical properties of keratin-based biomaterials. These inhibitors are often characterized by their ability to disrupt disulfide bond formation, which could alter the molecular architecture of keratin assemblies. The modification of keratin fiber assembly through KRTAP9-9 inhibition could lead to a range of alterations in the elasticity, tensile strength, and flexibility of keratin-based materials. This is of great relevance for applications that seek to manipulate natural fibers for use in textiles, biodegradable materials, and other industrial products. By studying the molecular interactions and structural consequences of KRTAP9-9 inhibition, researchers can gain deeper insights into the regulation of keratin structures and develop novel approaches to control the properties of keratin-containing materials.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis by interfering with the translocation step in protein synthesis, thereby potentially decreasing the overall levels of KRTAP9-9. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the levels of proteins targeted for degradation, possibly affecting the turnover of KRTAP9-9 if it is subject to proteasomal degradation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with mRNA synthesis by inhibiting RNA polymerase, which could reduce the transcription of the KRTAP9-9 gene. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Selectively inhibits RNA polymerase II and could thereby reduce the mRNA levels of KRTAP9-9, leading to decreased protein synthesis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A pyrimidine analog that disrupts RNA processing and protein synthesis, potentially affecting the expression of KRTAP9-9. | ||||||
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $59.00 | 2 | |
Uncouples oxidative phosphorylation, which could indirectly affect the energy-dependent synthesis of proteins like KRTAP9-9. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, which could affect the stability and function of proteins that are glycosylated, if KRTAP9-9 is among them. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by inhibiting the exchange of protein and other molecules between the endoplasmic reticulum and Golgi apparatus, potentially affecting KRTAP9-9 localization and function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits lysosomal enzyme activity and raises the lysosomal pH, which could affect the degradation of proteins like KRTAP9-9. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression and cellular differentiation, which could indirectly influence KRTAP9-9 expression during hair follicle development. | ||||||